Jane Street’s Kite Pharma, Inc. KITE Stock Holding History

Jane Street’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-21,600	Closed	-$3.88M	–	5574
2017 Q3	$3.88M	Sell	21,600 -3,900	-15%	-$543K	0.01%	1060
2017 Q2	$2.64M	Buy	25,500 +6,500	+34%	+$530K	0.01%	1233
2017 Q1	$1.49M	Buy	19,000 +13,000	+217%	+$804K	0.01%	1638
2016 Q4	$269K	Sell	6,000 -62,700	-91%	-$3.08M	﹤0.01%	3472
2016 Q3	$3.84M	Buy	+68,700	New	+$3.83M	0.02%	735
2015 Q3	–	Sell	-25,100	Closed	-$1.53M	–	4473
2015 Q2	$1.53M	Buy	+25,100	New	+$1.43M	0.01%	1187

Jane Street's KITE Position: Q4 2017 in Review

Jane Street sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 84,746 shares — an estimated $15.2M sold.

Jane Street first reported a position in KITE in Q3 2014 and held it in 10 quarters. The position peaked at $15.2M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Jane Street reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Jane Street sold 84,746 Kite Pharma, Inc. shares in Q4 2017, an estimated $15.2M.
Jane Street first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 10 quarters.
Jane Street's Kite Pharma, Inc. position peaked at $15.2M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Jane Street's 13F filing for Q4 2017, filed 15 Feb 2018.